CorMedix Inc.

CRMD · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$17,930-$46,339-$29,702-$28,210
Dep. & Amort.$310$71$85$62
Deferred Tax$0$0$0$0
Stock-Based Comp.$6,129$5,494$4,070$5,043
Change in WC-$39,408$2,230$1,066$1,835
Other Non-Cash$285$135$124$115
Operating Cash Flow-$50,615-$38,409-$24,357-$21,155
Investing Activities
PP&E Inv.-$116-$327-$219-$1,425
Net Acquisitions$0$0$0$0
Inv. Purchases-$26,770-$77,084-$31,140-$15,290
Inv. Sales/Matur.$48,116$60,350$27,650$7,580
Other Inv. Act.$0$0$0$0
Investing Cash Flow$21,231-$17,062-$3,709-$9,135
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$18,882$55,828$17,770$41,456
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$7,437$89$129$302
Financing Cash Flow$26,319$55,917$17,898$41,758
Forex Effect-$2$3-$9-$13
Net Chg. in Cash-$3,067$448-$10,177$11,454
Supplemental Information
Beg. Cash$43,823$43,375$53,551$42,097
End Cash$40,756$43,823$43,375$53,551
Free Cash Flow-$50,730-$38,737-$24,576-$22,581
CorMedix Inc. (CRMD) Financial Statements & Key Stats | AlphaPilot